(This measure has not been amended since it was passed by the House on October 7, 2004. The summary of that version is repeated here.)
Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health (NIH), to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.
Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.
[108th Congress Public Law 427]
[From the U.S. Government Publishing Office]
[DOCID: f:publ427.108]
[[Page 118 STAT. 2430]]
Public Law 108-427
108th Congress
An Act
To expand research information regarding multidisciplinary research
projects and epidemiological studies. <<NOTE: Nov. 30, 2004 - [H.R.
5213]>>
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <<NOTE: Research Reveiw
Act of 2004.>>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Research Review Act of 2004''.
SEC. 2. MULTI-DISCIPLINARY RESEARCH TEAM AND CONSORTIA REPORT.
(a) In General.--The Secretary of Health and Human Services
(referred to in this Act as the ``Secretary''), in coordination with the
Director of the National Institutes of Health, shall prepare a report
outlining the methods by which the Roadmap for Medical Research, an
initiative of such Institutes, has advanced the use of multidisciplinary
research teams and consortia of research institutions to advance
treatments, develop new therapies, and collaborate on clinical trials,
including with respect to spinal cord injury and paralysis research.
(b) Report.--Not later than February 1, 2005, the Secretary shall
submit the report under subsection (a) to the Committee on Energy and
Commerce of the House of Representatives and to the Committee on Health,
Education, Labor, and Pensions of the Senate.
SEC. 3. EPIDEMIOLOGICAL STUDY REPORT.
(a) In General.--The Secretary, acting through the Director of the
Centers for Disease Control and Prevention, shall prepare a report
outlining the epidemiological studies currently under way at such
Centers, future planned studies, the criteria involved in determining
what epidemiological studies to conduct, defer, or suspend, and the
scope of those studies, including with respect to the inflammatory bowel
disease epidemiological study. The report shall include a description of
the activities the Centers for Disease Control and Prevention undertakes
to establish partnerships with research and patient advocacy communities
to expand epidemiological studies.
(b) Report.--Not later than May 1, 2005, the Secretary shall submit
the report under subsection (a) to the Committee on Energy and Commerce
of the House of Representatives and to the Committee on Health,
Education, Labor, and Pensions of the Senate.
[[Page 118 STAT. 2431]]
SEC. 4. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE ON MEDICARE AND
MEDICAID COVERAGE STANDARDS.
(a) In General.--The Comptroller General of the United States shall
conduct a study on the coverage standards that, under the programs under
titles XVIII and XIX of the Social Security Act (commonly known as
Medicare and Medicaid, respectively), apply to patients with
inflammatory bowel disease for the following therapies:
(1) Parenteral nutrition.
(2) Enteral nutrition formula.
(3) Medically necessary food products.
(4) Ostomy supplies.
(5) Therapies approved by the Food and Drug Administration
for Crohn's disease and ulcerative colitis.
(b) Content.--The study under subsection (a) shall take into account
the appropriate outpatient or home health care delivery settings.
(c) Report.--Not later than six months after the date of the
enactment of this Act, the Comptroller General shall submit to the
Congress a report describing the findings of the study under subsection
(a).
SEC. 5. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE INVOLVING DISABILITY
INSURANCE.
(a) In General.--The Comptroller General of the United States shall
conduct a study of the problems patients encounter when applying for
disability insurance benefits under title II of the Social Security Act.
The study shall include recommendations for improving the application
process for patients with inflammatory bowel disease.
(b) Report.--Not later than six months after the date of the
enactment of this Act, the Comptroller General shall submit to the
Congress a report describing the findings of the study under subsection
(a).
Approved November 30, 2004.
LEGISLATIVE HISTORY--H.R. 5213:
---------------------------------------------------------------------------
CONGRESSIONAL RECORD, Vol. 150 (2004):
Oct. 6, 7, considered and passed House.
Nov. 16, considered and passed Senate.
<all>
Referred to the Subcommittee on Health.
Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H8255-8257)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5213.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H8650-8651)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504).(text: CR 10/6/2004 H8255)
Roll Call #504 (House)On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504). (text: CR 10/6/2004 H8255)
Roll Call #504 (House)Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate, read twice.
Enacted as Public Law 108-427
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
Referred to the Subcommittee on Health.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S11389)
Passed Senate without amendment by Unanimous Consent. (consideration: CR S11389)
Message on Senate action sent to the House.
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 108-427.
Became Public Law No: 108-427.